Current and future biomarkers in allergic asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 71, Issue 4, 2016, Pages 475-494

  Zissler, U M ^a   Esser Von Bieren, J ^a   Jakwerth, C A ^a   Chaker, A M ^a,b   Schmidt Weber, C B ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

allergic asthma; allergic rhinitis; epithelium; infiltrate; local biomarkers

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; EOTAXIN 3; OSTEOPONTIN; MEMBRANE ANTIGEN;

AIRWAY REMODELING; ALLERGIC ASTHMA; ALLERGIC RHINITIS; B LYMPHOCYTE; BASOPHIL; CELL COUNT; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; EOSINOPHILIC ASTHMA; EPITHELIUM; EXOSOME; GENETIC ASSOCIATION; HUMAN; INFLAMMATION; LUNG FUNCTION; LYMPHOCYTIC INFILTRATION; MEMBRANE MICROPARTICLE; MICROBIOME; NEUTROPHIL; NEUTROPHILIC ASTHMA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; REVIEW; SPUTUM; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; TH22 CELL; TH9 CELL; UPPER RESPIRATORY TRACT; ADVERSE EFFECTS; ANIMAL; ASTHMA; CYTOLOGY; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MICROFLORA;

AIRWAY REMODELING; ANIMALS; ANTIGENS, SURFACE; ASTHMA; BIOMARKERS; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; MICROBIOTA;

EID: 84955113426     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12828     Document Type: Review

References (320)

1. Vijverberg SJ, Hilvering B, Raaijmakers JA, Lammers JW, Maitland-van der Zee AH, Koenderman L,. Clinical utility of asthma biomarkers: from bench to bedside. Biologics 2013; 7: 199-210.
2. Vijverberg SJ, Koenderman L, Koster ES, van der Ent CK, Raaijmakers JA, Maitland-van der Zee AH,. Biomarkers of therapy responsiveness in asthma: pitfalls and promises. Clin Exp Allergy 2011; 41: 615-629.
3. Deykin A,. Biomarker-driven care in asthma: are we there? J Allergy Clin Immunol 2006; 118: 565-568.
4. Leung TF, Ko FW, Wong GW,. Recent advances in asthma biomarker research. Ther Adv Respir Dis 2013; 7: 297-308.
5. Rossi R, De Palma A, Benazzi L, Riccio AM, Canonica GW, Mauri P,. Biomarker discovery in asthma and COPD by proteomic approaches. Proteomics Clin Appl 2014; 8: 901-915.
6. Szefler SJ,. Individualizing asthma therapy: application of biomarkers. J Asthma 2008; 45 (Suppl 1): 29-31.
7. Wenzel SE,. Complex phenotypes in asthma: current definitions. Pulm Pharmacol Ther 2013; 26: 710-715.
8. Bannier MA, van de Kant KD, Jobsis Q, Dompeling E,. Biomarkers to predict asthma in wheezing preschool children. Clin Exp Allergy 2015; 45: 1040-1050.
9. Carson CG, Rasmussen MA, Thyssen JP, Menne T, Bisgaard H,. Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study. PLoS One 2012; 7: e48678.
10. Ducharme FM, Tse SM, Chauhan B,. Diagnosis, management, and prognosis of preschool wheeze. Lancet 2014; 383: 1593-1604.
11. Nino G, Huseni S, Perez GF, Pancham K, Mubeen H, Abbasi A, et al., Directional secretory response of double stranded RNA-induced thymic stromal lymphopoietin (TSLP) and CCL11/eotaxin-1 in human asthmatic airways. PLoS One 2014; 9: e115398.
12. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al., A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010; 363: 1211-1221.
13. Chauhan A, Singh M, Agarwal A, Paul N,. Correlation of TSLP, IL-33, and CD4+ CD25+ FOXP3+ T regulatory (Treg) in pediatric asthma. J Asthma 2015; 52: 868-872.
14. Miljkovic D, Bassiouni A, Cooksley C, Ou J, Hauben E, Wormald PJ, et al., Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis. Allergy 2014; 69: 1154-1161.
15. Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, et al., Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011; 12: 1055-1062.
16. Ho J, Bailey M, Zaunders J, Mrad N, Sacks R, Sewell W, et al., Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. Clin Exp Allergy 2015; 45: 394-403.
17. Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S, et al., Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 2001; 164: 277-281.
18. Bartemes KR, Kephart GM, Fox SJ, Kita H,. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol 2014; 134: 671-678.
19. Vocca L, Di Sano C, Uasuf CG, Sala A, Riccobono L, Gangemi S, et al., IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases. Immunobiology 2015; 220: 954-963.
20. Carpio-Pedroza JC, Vaughan G, del Rio-Navarro BE, del Rio-Chivardi JM, Vergara-Castaneda A, Jimenez-Zamudio LA, et al., Participation of CD161(+) and invariant natural killer T cells in pediatric asthma exacerbations. Allergy Asthma Proc 2013; 34: 84-92.
21. Gold DR, Bloomberg GR, Cruikshank WW, Visness CM, Schwarz J, Kattan M, et al., Parental characteristics, somatic fetal growth, and season of birth influence innate and adaptive cord blood cytokine responses. J Allergy Clin Immunol 2009; 124: 1078-1087.
22. Lombard C, Andre F, Paul J, Wanty C, Vosters O, Bernard P, et al., Clinical Parameters vs Cytokine Profiles as Predictive Markers of IgE-Mediated Allergy in Young Children. PLoS One 2015; 10: e0132753.
23. Wood RA, Bloomberg GR, Kattan M, Conroy K, Sandel MT, Dresen A, et al., Relationships among environmental exposures, cord blood cytokine responses, allergy, and wheeze at 1 year of age in an inner-city birth cohort (Urban Environment and Childhood Asthma study). J Allergy Clin Immunol 2011; 127: 913-919.
24. Mete E, Erdemli K, Bavbek N, Erturac M,. High levels of cord serum eosinophil cationic protein predict the risk of atopy. J Asthma 2004; 41: 679-682.
25. Lopez-Guisa JM, Powers C, File D, Cochrane E, Jimenez N, Debley JS,. Airway epithelial cells from asthmatic children differentially express proremodeling factors. J Allergy Clin Immunol 2012; 129: 990-997.
26. Vizmanos-Lamotte G, Moreno-Galdo A, Munoz X, Gomez-Olles S, Gartner S, Cruz MJ,. Induced sputum cell count and cytokine profile in atopic and non-atopic children with asthma. Pediatr Pulmonol 2013; 48: 1062-1069.
27. Efthimiadis A, Spanevello A, Hamid Q, Kelly MM, Linden M, Louis R, et al., Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl 2002; 37: 19s-23s.
28. Spanevello A, Migliori GB, Sharara A, Ballardini L, Bridge P, Pisati P, et al., Induced sputum to assess airway inflammation: a study of reproducibility. Clin Exp Allergy 1997; 27: 1138-1144.
29. Gibson PG, Grootendor DC, Henry RL, Pin I, Rytila PH, Wark P, et al., Sputum induction in children. Eur Respir J Suppl 2002; 37: 44s-46s.
30. Idzko M, Pitchford S, Page C,. Role of platelets in allergic airway inflammation. J Allergy Clin Immunol 2015; 135: 1416-1423.
31. Tornhamre S, Ehnhage A, Kolbeck KG, Edenius C, Lindgren JA,. Uncoupled regulation of leukotriene C4 synthase in platelets from aspirin-intolerant asthmatics and healthy volunteers after aspirin treatment. Clin Exp Allergy 2002; 32: 1566-1573.
32. Johansson MW, Han ST, Gunderson KA, Busse WW, Jarjour NN, Mosher DF,. Platelet activation, P-selectin, and eosinophil beta1-integrin activation in asthma. Am J Respir Crit Care Med 2012; 185: 498-507.
33. Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, Skiepko R, Mroczko B, Szmitkowski M,. Changes in RANTES and beta-thromboglobulin after intensive exercise in patients with allergic asthma. Int Arch Allergy Immunol 2009; 148: 31-40.
34. Knauer KA, Lichtenstein LM, Adkinson NF Jr, Fish JE,. Platelet activation during antigen-induced airway reactions in asthmatic subjects. N Engl J Med 1981; 304: 1404-1407.
35. Durk T, Duerschmied D, Muller T, Grimm M, Reuter S, Vieira RP, et al., Production of serotonin by tryptophan hydroxylase 1 and release via platelets contribute to allergic airway inflammation. Am J Respir Crit Care Med 2013; 187: 476-485.
36. Baigelman W, Chodosh S, Pizzuto D, Cupples LA,. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma. Am J Med 1983; 75: 929-936.
37. Corrigan CJ, Kay AB,. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13: 501-507.
38. Wenzel S,. Mechanisms of severe asthma. Clin Exp Allergy 2003; 33: 1622-1628.
39. Louis R, Sele J, Henket M, Cataldo D, Bettiol J, Seiden L, et al., Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy 2002; 57: 907-912.
40. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R,. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000; 161: 9-16.
41. Jatakanon A, Lim S, Barnes PJ,. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000; 161: 64-72.
42. in't Veen JC, Smits HH, Hiemstra PS, Zwinderman AE, Sterk PJ, Bel EH,. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med 1999; 160: 93-99.
43. Pizzichini MM, Pizzichini E, Clelland L, Efthimiadis A, Pavord I, Dolovich J, et al., Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J 1999; 13: 15-21.
44. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al., Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360: 973-984.
45. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, et al., Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2144-2148.
46. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, et al., Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360: 985-993.
47. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al., Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715-1721.
48. de la Fuente T,. P, Romagnoli M, Carlsson L, Godard P, Bousquet J, Chanez P. Eosinophilic inflammation assessed by induced sputum in corticosteroid-dependent asthma. Respir Med 1999; 93: 183-189.
49. Hastie AT, Moore WC, Meyers DA, Vestal PL, Li H, Peters SP, et al., Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol 2010; 125: 1028-1036.
50. Tak T, Hilvering B, Tesselaar K, Koenderman L,. Similar activation state of neutrophils in sputum of asthma patients irrespective of sputum eosinophilia. Clin Exp Immunol 2015; 182: 204-212.
51. De Boever EH, Ashman C, Cahn AP, Locantore NW, Overend P, Pouliquen IJ, et al., Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a randomized trial. J Allergy Clin Immunol 2014; 133: 989-996.
52. Cahill KN, Bensko JC, Boyce JA, Laidlaw TM,. Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2015; 135: 245-252.
53. Kleinschmidt TK, Haraldsson M, Basavarajappa D, Lundeberg E, Thulasingam M, Ekoff M, et al., Tandem Benzophenone Amino Pyridines, Potent and Selective Inhibitors of Human Leukotriene C4 Synthase. J Pharmacol Exp Ther 2015; 355: 108-116.
54. Macfarlane AJ, Dworski R, Sheller JR, Pavord ID, Kay AB, Barnes NC,. Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. Am J Respir Crit Care Med 2000; 161: 1553-1558.
55. Schauer U, Alefsen S, Jager R, Riedel F, Rieger CH,. Blood eosinophils, leukotriene C4 generation, and bronchial hyperreactivity in formerly preterm infants. Arch Dis Child 1994; 71: 506-510.
56. Klaassen EM, van de Kant KD, Jobsis Q, Penders J, van Schooten FJ, Quaak M, et al., Integrative genomic analysis identifies a role for intercellular adhesion molecule 1 in childhood asthma. Pediatr Allergy Immunol 2014; 25: 166-172.
57. Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ,. Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med 2002; 165: 1290-1293.
58. Profita M, La Grutta S, Carpagnano E, Riccobono L, Di Giorgi R, Bonanno A, et al., Noninvasive methods for the detection of upper and lower airway inflammation in atopic children. J Allergy Clin Immunol 2006; 118: 1068-1074.
59. Trischler J, Muller CM, Konitzer S, Prell E, Korten I, Unverzagt S, et al., Elevated exhaled leukotriene B(4) in the small airway compartment in children with asthma. Ann Allergy Asthma Immunol 2015; 114: 111-116.
60. Raedler D, Ballenberger N, Klucker E, Bock A, Otto R, Prazeres da Costa O, et al., Identification of novel immune phenotypes for allergic and nonallergic childhood asthma. J Allergy Clin Immunol 2015; 135: 81-91.
61. Illi S, von Mutius E, Lau S, Nickel R, Niggemann B, Sommerfeld C, et al., The pattern of atopic sensitization is associated with the development of asthma in childhood. J Allergy Clin Immunol 2001; 108: 709-714.
62. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Host A, et al., Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62: 943-948.
63. Niggemann B, Jacobsen L, Dreborg S, Ferdousi HA, Halken S, Host A, et al., Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy 2006; 61: 855-859.
64. Lazic N, Roberts G, Custovic A, Belgrave D, Bishop CM, Winn J, et al., Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts. Allergy 2013; 68: 764-770.
65. Simpson A, Lazic N, Belgrave DC, Johnson P, Bishop C, Mills C, et al., Patterns of IgE responses to multiple allergen components and clinical symptoms at age 11 years. J Allergy Clin Immunol 2015; 136: 1224-1231.
66. Shamji MH, Ljorring C, Francis JN, Calderon MA, Larche M, Kimber I, et al., Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Allergy 2012; 67: 217-226.
67. Aghayan-Ugurluoglu R, Ball T, Vrtala S, Schweiger C, Kraft D, Valenta R,. Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens. J Allergy Clin Immunol 2000; 105: 803-813.
68. Hofer MF, Jirapongsananuruk O, Trumble AE, Leung DY,. Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J Allergy Clin Immunol 1998; 101: 96-102.
69. Czarnowicki T, Gonzalez J, Bonifacio KM, Shemer A, Xiangyu P, Kunjravia N, et al., Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis. J Allergy Clin Immunol 2016; 137: 118-129.
70. Wong KJ, Timbrell V, Xi Y, Upham JW, Collins AM, Davies JM,. IgE+ B cells are scarce, but allergen-specific B cells with a memory phenotype circulate in patients with allergic rhinitis. Allergy 2015; 70: 420-428.
71. Henriques A, Nunes R, Loureiro G, Martinho A, Pais M, Segorbe-Luis A, et al., Alterations on peripheral blood B cell subsets induced by allergic rhinitis. Inflamm Res 2015; 64: 145-149.
72. Xiao L, Wei Y, Zhang YN, Luo X, Yang BY, Yu SF, et al., Increased IL-21 expression in chronic rhinosinusitis with nasalpolyps. Clin Exp Allergy 2015; 45: 404-413.
73. KleinJan A, Vinke JG, Severijnen LW, Fokkens WJ,. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J 2000; 15: 491-497.
74. Platts-Mills TA,. Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol 1979; 122: 2218-2225.
75. Wilson DR, Merrett TG, Varga EM, Smurthwaite L, Gould HJ, Kemp M, et al., Increases in allergen-specific IgE in BAL after segmental allergen challenge in atopic asthmatics. Am J Respir Crit Care Med 2002; 165: 22-26.
76. Peters MC, Mekonnen ZK, Yuan S, Bhakta NR, Woodruff PG, Fahy JV,. Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol 2014; 133: 388-394.
77. Park SW, Jangm HK, An MH, Min JW, Jang AS, Lee JH, et al., Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis: comparison with asthma. Chest 2005; 128: 1921-1927.
78. Leckie MJ, Jenkins GR, Khan J, Smith SJ, Walker C, Barnes PJ, et al., Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+). Thorax 2003; 58: 23-29.
79. Lee YC, Lee KH, Lee HB, Rhee YK,. Serum levels of interleukins (IL)-4, IL-5, IL-13, and interferon-gamma in acute asthma. J Asthma 2001; 38: 665-671.
80. Xue L, Gyles SL, Wettey FR, Gazi L, Townsend E, Hunter MG, et al., Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol 2005; 175: 6531-6536.
81. Tang F, Wang F, An L, Wang X,. Upregulation of Tim-3 on CD4(+) T cells is associated with Th1/Th2 imbalance in patients with allergic asthma. Int J Clin Exp Med 2015; 8: 3809-3816.
82. Agarwal A, Singh M, Chatterjee BP, Chauhan A, Chakraborti A,. Interplay of T Helper 17 Cells with CD4(+)CD25(high) FOXP3(+) Tregs in Regulation of Allergic Asthma in Pediatric Patients. Int J Pediatr 2014; 2014: 636238.
83. Zhang Q, Qian FH, Liu H, Zhou LF, Huang M, Zhang XL, et al., Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid. Chin Med J (Engl) 2008; 121: 205-212.
84. Wang LL, Tang HP, Shi GC, Wan HY, Tang W, Hou XX, et al., CD39/CD73 and the imbalance of Th17 cells and regulatory T cells in allergic asthma. Mol Med Rep 2013; 8: 1432-1438.
85. Eyerich S, Onken AT, Weidinger S, Franke A, Nasorri F, Pennino D, et al., Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med 2011; 365: 231-238.
86. Pennino D, Bhavsar PK, Effner R, Avitabile S, Venn P, Quaranta M, et al., IL-22 suppresses IFN-gamma-mediated lung inflammation in asthmatic patients. J Allergy Clin Immunol 2013; 131: 562-570.
87. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, et al., Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009; 119: 3573-3585.
88. Pociask DA, Scheller EV, Mandalapu S, McHugh KJ, Enelow RI, Fattman CL, et al., IL-22 is essential for lung epithelial repair following influenza infection. Am J Pathol 2013; 182: 1286-1296.
89. Bai X, Sun J, Wang W, Shan Z, Zheng H, Li Y, et al., Increased differentiation of Th22 cells in Hashimoto's thyroiditis. Endocr J 2014; 61: 1181-1190.
90. Huang YH, Cao YF, Jiang ZY, Zhang S, Gao F,. Th22 cell accumulation is associated with colorectal cancer development. World J Gastroenterol 2015; 21: 4216-4224.
91. Lai R, Xiang X, Mo R, Bao R, Wang P, Guo S, et al., Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury. J Hepatol 2015; 63: 148-155.
92. Page EE, Greathead L, Metcalf R, Clark SA, Hart M, Fuchs D, et al., Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection. J Acquir Immune Defic Syndr 2014; 67: 227-235.
93. Hoppenot D, Malakauskas K, Lavinskiene S, Bajoriuniene I, Kalinauskaite V, Sakalauskas R,. Peripheral blood Th9 cells and eosinophil apoptosis in asthma patients. Medicina (Kaunas) 2015; 51: 10-17.
94. Irvin C, Zafar I, Good J, Rollins D, Christianson C, Gorska MM, et al., Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma. J Allergy Clin Immunol 2014; 134: 1175-1186.
95. Bellini A, Marini MA, Bianchetti L, Barczyk M, Schmidt M, Mattoli S,. Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. Mucosal Immunol 2012; 5: 140-149.
96. Bianchetti L, Barczyk M, Cardoso J, Schmidt M, Bellini A, Mattoli S,. Extracellular matrix remodelling properties of human fibrocytes. J Cell Mol Med 2012; 16: 483-495.
97. Akdis M, Akdis CA,. IgE class switching and cellular memory. Nat Immunol 2012; 13: 312-314.
98. Schmidt-Weber CB, Akdis M, Akdis CA,. TH17 cells in the big picture of immunology. J Allergy Clin Immunol 2007; 120: 247-254.
99. Zissler UM, Chaker AM, Effner R, Ulrich M, Guerth F, Piontek G, et al., Interleukin-4 and interferon-gamma orchestrate an epithelial polarization in the airways. Mucosal Immunol 2015; in press. doi: 10.1038/mi.2015.110.
100. Baumann R, Rabaszowski M, Stenin I, Tilgner L, Scheckenbach K, Wiltfang J, et al., Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge. Am J Rhinol Allergy 2013; 27: 266-272.
101. Eickmeier O, Huebner M, Herrmann E, Zissler U, Rosewich M, Baer PC, et al., Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function. Cytokine 2010; 50: 152-157.
102. Leonardi A,. Allergy and allergic mediators in tears. Exp Eye Res 2013; 117: 106-117.
103. Corrigan CJ, Wang W, Meng Q, Fang C, Eid G, Caballero MR, et al., Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J Allergy Clin Immunol 2011; 128: 116-124.
104. Quaranta M, Knapp B, Garzorz N, Mattii M, Pullabhatla V, Pennino D, et al., Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. Sci Transl Med 2014; 6: 244ra290.
105. Han MK, Zhou Y, Murray S, Tayob N, Noth I, Lama VN, et al., Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. Lancet Respir Med 2014; 2: 548-556.
106. Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, et al., A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007; 357: 2016-2027.
107. Konradsen JR, James A, Nordlund B, Reinius LE, Soderhall C, Melen E, et al., The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma. J Allergy Clin Immunol 2013; 132: 328-335.
108. Park CS, Lee YS, Kwon HS, Lee T, Kim TB, Moon KA, et al., Chlamydophila pneumoniae inhibits corticosteroid-induced suppression of metalloproteinase-9 and tissue inhibitor metalloproteinase-1 secretion by human peripheral blood mononuclear cells. J Med Microbiol 2012; 61: 705-711.
109. Samitas K, Zervas E, Vittorakis S, Semitekolou M, Alissafi T, Bossios A, et al., Osteopontin expression and relation to disease severity in human asthma. Eur Respir J 2011; 37: 331-341.
110. Choy DF, Modrek B, Abbas AR, Kummerfeld S, Clark HF, Wu LC, et al., Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways. J Immunol 2011; 186: 1861-1869.
111. Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, et al., Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 2012; 130: 647-654.
112. Delimpoura V, Bakakos P, Tseliou E, Bessa V, Hillas G, Simoes DC, et al., Increased levels of osteopontin in sputum supernatant in severe refractory asthma. Thorax 2010; 65: 782-786.
113. Hillas G, Loukides S, Kostikas K, Simoes D, Petta V, Konstantellou E, et al., Increased levels of osteopontin in sputum supernatant of smoking asthmatics. Cytokine 2013; 61: 251-255.
114. Boulay ME, Prince P, Deschesnes F, Chakir J, Boulet LP,. Metalloproteinase-9 in induced sputum correlates with the severity of the late allergen-induced asthmatic response. Respiration 2004; 71: 216-224.
115. Vignola AM, Riccobono L, Mirabella A, Profita M, Chanez P, Bellia V, et al., Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998; 158: 1945-1950.
116. Cataldo DD, Gueders M, Munaut C, Rocks N, Bartsch P, Foidart JM, et al., Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. Lab Invest 2004; 84: 418-424.
117. Asai K, Kanazawa H, Kamoi H, Shiraishi S, Hirata K, Yoshikawa J,. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy 2003; 33: 595-599.
118. Abdel-Rahman AM, el-Sahrigy SA, Bakr SI,. A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. Chest 2006; 129: 266-271.
119. Johansson MW, Kruger SJ, Schiebler ML, Evans MD, Sorkness RL, Denlinger LC, et al., Markers of vascular perturbation correlate with airway structural change in asthma. Am J Respir Crit Care Med 2013; 188: 167-178.
120. Han Z,. Junxu, Zhong N. Expression of matrix metalloproteinases MMP-9 within the airways in asthma. Respir Med 2003; 97: 563-567.
121. Karakoc GB, Yukselen A, Yilmaz M, Altintas DU, Kendirli SG,. Exhaled breath condensate MMP-9 level and its relationship with asthma severity and interleukin-4/10 levels in children. Ann Allergy Asthma Immunol 2012; 108: 300-304.
122. Boonpiyathad S, Pornsuriyasak P, Buranapraditkun S, Klaewsongkram J,. Interleukin-2 levels in exhaled breath condensates, asthma severity, and asthma control in nonallergic asthma. Allergy Asthma Proc 2013; 34: e35-e41.
123. Matsunaga K, Yanagisawa S, Ichikawa T, Ueshima K, Akamatsu K, Hirano T, et al., Airway cytokine expression measured by means of protein array in exhaled breath condensate: correlation with physiologic properties in asthmatic patients. J Allergy Clin Immunol 2006; 118: 84-90.
124. Ying S, Robinson DS, Meng Q, Rottman J, Kennedy R, Ringler DJ, et al., Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 1997; 27: 3507-3516.
125. Ying S, Meng Q, Zeibecoglou K, Robinson DS, Macfarlane A, Humbert M, et al., Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol 1999; 163: 6321-6329.
126. Coleman JM, Naik C, Holguin F, Ray A, Ray P, Trudeau JB, et al., Epithelial eotaxin-2 and eotaxin-3 expression: relation to asthma severity, luminal eosinophilia and age at onset. Thorax 2012; 67: 1061-1066.
127. Saha SK, Berry MA, Parker D, Siddiqui S, Morgan A, May R, et al., Increased sputum and bronchial biopsy IL-13 expression in severe asthma. J Allergy Clin Immunol 2008; 121: 685-691.
128. Ying S, O'Connor B, Ratoff J, Meng Q, Mallett K, Cousins D, et al., Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005; 174: 8183-8190.
129. Sekiya T, Yamada H, Yamaguchi M, Yamamoto K, Ishii A, Yoshie O, et al., Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. Allergy 2002; 57: 173-177.
130. Zietkowski Z, Tomasiak-Lozowska MM, Skiepko R, Zietkowska E, Bodzenta-Lukaszyk A,. Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients. Respir Res 2010; 11: 110.
131. Zietkowski Z, Skiepko R, Tomasiak-Lozowska MM, Bodzenta-Lukaszyk A,. Airway inflammation and eotaxin in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy. Adv Med Sci 2011; 56: 318-322.
132. Viksman MY, Bochner BS, Peebles RS, Schleimer RP, Liu MC,. Expression of activation markers on alveolar macrophages in allergic asthmatics after endobronchial or whole-lung allergen challenge. Clin Immunol 2002; 104: 77-85.
133. Carpagnano GE, Foschino Barbaro MP, Cagnazzo M, Di Gioia G, Giliberti T, Di Matteo C, et al., Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge. Chest 2005; 128: 3159-3166.
134. Muro S, Taha R, Tsicopoulos A, Olivenstein R, Tonnel AB, Christodoulopoulos P, et al., Expression of IL-15 in inflammatory pulmonary diseases. J Allergy Clin Immunol 2001; 108: 970-975.
135. Torrego A, Hew M, Oates T, Sukkar M,. Fan Chung K. Expression and activation of TGF-beta isoforms in acute allergen-induced remodelling in asthma. Thorax 2007; 62: 307-313.
136. Wu J, Wang G, Hao J, Gong W,. The correlation between IL-20 and the Th2 immune response in human asthma. Asian Pac J Allergy Immunol 2014; 32: 316-320.
137. Poole A, Urbanek C, Eng C, Schageman J, Jacobson S, O'Connor BP, et al., Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J Allergy Clin Immunol 2014; 133: 670-678.
138. Paplinska M, Hermanowicz-Salamon J, Nejman-Gryz P, Bialek-Gosk K, Rubinsztajn R, Arcimowicz M, et al., Expression of eotaxins in the material from nasal brushing in asthma, allergic rhinitis and COPD patients. Cytokine 2012; 60: 393-399.
139. Kinhult J, Egesten A, Benson M, Uddman R, Cardell LO,. Increased expression of surface activation markers on neutrophils following migration into the nasal lumen. Clin Exp Allergy 2003; 33: 1141-1146.
140. Bochkov YA, Hanson KM, Keles S, Brockman-Schneider RA, Jarjour NN, Gern JE,. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol 2010; 3: 69-80.
141. Nagarkar DR, Poposki JA, Tan BK, Comeau MR, Peters AT, Hulse KE, et al., Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol 2013; 132: 593-600.
142. O'Neil SE, Malmhall C, Samitas K, Pullerits T, Bossios A, Lotvall J,. Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment. Allergy Asthma Clin Immunol 2010; 6: 28.
143. Colavita AM, Hastie AT, Musani AI, Pascual RM, Reinach AJ, Lustine HT, et al., Kinetics of IL-10 production after segmental antigen challenge of atopic asthmatic subjects. J Allergy Clin Immunol 2000; 106: 880-886.
144. Batra V, Musani AI, Hastie AT, Khurana S, Carpenter KA, Zangrilli JG, et al., Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin Exp Allergy 2004; 34: 437-444.
145. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR,. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993; 8: 35-42.
146. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC Jr,. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992; 146: 109-115.
147. Foley SC, Mogas AK, Olivenstein R, Fiset PO, Chakir J, Bourbeau J, et al., Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J Allergy Clin Immunol 2007; 119: 863-871.
148. El-Shazly AE, Henket M, Lefebvre PP, Louis R,. 2B4 (CD244) is involved in eosinophil adhesion and chemotaxis, and its surface expression is increased in allergic rhinitis after challenge. Int J Immunopathol Pharmacol 2011; 24: 949-960.
149. Monteiro RC, Hostoffer RW, Cooper MD, Bonner JR, Gartland GL, Kubagawa H,. Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 1993; 92: 1681-1685.
150. Sihra BS, Kon OM, Grant JA, Kay AB,. Expression of high-affinity IgE receptors (Fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations. J Allergy Clin Immunol 1997; 99: 699-706.
151. Rajakulasingam K, Till S, Ying S, Humbert M, Barkans J, Sullivan M, et al., Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma. Am J Respir Crit Care Med 1998; 158: 233-240.
152. Pelikan Z,. Expression of surface markers on the blood cells during the delayed asthmatic response to allergen challenge. Allergy Rhinol (Providence) 2014; 5: 96-109.
153. Liu LY, Sedgwick JB, Bates ME, Vrtis RF, Gern JE, Kita H, et al., Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. J Immunol 2002; 169: 6452-6458.
154. Lensmar C, Katchar K, Eklund A, Grunewald J, Wahlstrom J,. Phenotypic analysis of alveolar macrophages and lymphocytes following allergen inhalation by atopic subjects with mild asthma. Respir Med 2006; 100: 918-925.
155. Virchow JC Jr, Julius P, Matthys H, Kroegel C, Luttmann W,. CD14 expression and soluble CD14 after segmental allergen provocation in atopic asthma. Eur Respir J 1998; 11: 317-323.
156. Winkler C, Witte L, Moraw N, Faulenbach C, Muller M, Holz O, et al., Impact of endobronchial allergen provocation on macrophage phenotype in asthmatics. BMC Immunol 2014; 15: 12.
157. Roszer T,. Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. Mediators Inflamm 2015; 2015: 816460.
158. Spears M, McSharry C, Chaudhuri R, Weir CJ, de Wet C, Thomson NC,. Smoking in asthma is associated with elevated levels of corticosteroid resistant sputum cytokines-an exploratory study. PLoS One 2013; 8: e71460
159. Castanhinha S, Sherburn R, Walker S, Gupta A, Bossley CJ, Buckley J, et al., Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33. J Allergy Clin Immunol 2015; 136: 312-322.
160. Jackson DJ, Makrinioti H, Rana BM, Shamji BW, Trujillo-Torralbo MB, Footitt J, et al., IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med 2014; 190: 1373-1382.
161. Garcia G, Humbert M, Capel F, Rimaniol AC, Escourrou P, Emilie D, et al., Chemokine receptor expression on allergen-specific T cells in asthma and allergic bronchopulmonary aspergillosis. Allergy 2007; 62: 170-177.
162. Ocmant A, Peignois Y, Mulier S, Hanssens L, Michils A, Schandene L,. Flow cytometry for basophil activation markers: the measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergy. J Immunol Methods 2007; 320: 40-48.
163. He SH, Zhang HY, Zeng XN, Chen D, Yang PC,. Mast cells and basophils are essential for allergies: mechanisms of allergic inflammation and a proposed procedure for diagnosis. Acta Pharmacol Sin 2013; 34: 1270-1283.
164. Perry MM, Baker JE, Gibeon DS, Adcock IM, Chung KF,. Airway smooth muscle hyperproliferation is regulated by microRNA-221 in severe asthma. Am J Respir Cell Mol Biol 2014; 50: 7-17.
165. Naseer T, Minshall EM, Leung DY, Laberge S, Ernst P, Martin RJ, et al., Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997; 155: 845-851.
166. Khor YH, Feltis BN, Reid DW, Ward C, Johns DP, Wood-Baker R, et al., Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction. Clin Exp Allergy 2007; 37: 1189-1198.
167. Feltis BN, Reid DW, Ward C, Walters EH,. BAL eotaxin and IL-5 in asthma, and the effects of inhaled corticosteroid and beta2 agonist. Respirology 2004; 9: 507-513.
168. Goleva E, Hauk PJ, Hall CF, Liu AH, Riches DW, Martin RJ, et al., Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J Allergy Clin Immunol 2008; 122: 550-559.
169. Erin EM, Zacharasiewicz AS, Nicholson GC, Tan AJ, Higgins LA, Williams TJ, et al., Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge. Clin Exp Allergy 2005; 35: 1608-1614.
170. Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, Ruckert B, et al., Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114: 1425-1433.
171. Dumitru AF, Shamji M, Wagenmann M, Hindersin S, Scheckenbach K, Greve J, et al., Petasol butenoate complex (Ze 339) relieves allergic rhinitis-induced nasal obstruction more effectively than desloratadine. J Allergy Clin Immunol 2011; 127: 1515-1521.
172. Gernez Y, Tirouvanziam R, Nguyen KD, Herzenberg LA, Krensky AM, Nadeau KC,. Altered phosphorylated signal transducer and activator of transcription profile of CD4+CD161+ T cells in asthma: modulation by allergic status and oral corticosteroids. J Allergy Clin Immunol 2007; 120: 1441-1448.
173. Scadding GW, Eifan AO, Lao-Araya M, Penagos M, Poon SY, Steveling E, et al., Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge. Allergy 2015; 70: 689-696.
174. Konno S, Golden DB, Schroeder J, Hamilton RG, Lichtenstein LM, Huang SK,. Increased expression of osteopontin is associated with long-term bee venom immunotherapy. J Allergy Clin Immunol 2005; 115: 1063-1067.
175. Chaker AM, Shamji MH, Dumitru FA, Calderon MA, Scadding GW, Makatsori M, et al., Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: a randomized controlled trial. J Allergy Clin Immunol 2016; 137: 452-461.
176. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, et al., Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 2013; 368: 2455-2466.
177. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, et al., Lebrikizumab treatment in adults with asthma. N Engl J Med 2011; 365: 1088-1098.
178. Seys SF, Grabowski M, Adriaensen W, Decraene A, Dilissen E, Vanoirbeek JA, et al., Sputum cytokine mapping reveals an 'IL-5, IL-17A, IL-25-high' pattern associated with poorly controlled asthma. Clin Exp Allergy 2013; 43: 1009-1017.
179. Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, et al., IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006; 7: 135.
180. Li L, Wan C, Wen F,. An unexpected role for serum uric acid as a biomarker for severity of asthma exacerbation. Asian Pac J Allergy Immunol 2014; 32: 93-99.
181. Warwick G, Thomas PS, Yates DH,. Non-invasive biomarkers in exacerbations of obstructive lung disease. Respirology 2013; 18: 874-884.
182. Shipe R, Burdick MD, Strieter BA, Liu L, Shim YM, Sung SS, et al., Number, activation, and differentiation of circulating fibrocytes correlate with asthma severity. J Allergy Clin Immunol 2016; 137: 750-757.
183. Wang CH, Punde TH, Huang CD, Chou PC, Huang TT, Wu WH, et al., Fibrocyte trafficking in patients with chronic obstructive asthma and during an acute asthma exacerbation. J Allergy Clin Immunol 2015; 135: 1154-1162.
184. Loureiro CC, Duarte IF, Gomes J, Carrola J, Barros AS, Gil AM, et al., Urinary metabolomic changes as a predictive biomarker of asthma exacerbation. J Allergy Clin Immunol 2014; 133: 261-263.
185. Rabinovitch N, Reisdorph N, Silveira L, Gelfand EW,. Urinary leukotriene E(4) levels identify children with tobacco smoke exposure at risk for asthma exacerbation. J Allergy Clin Immunol 2011; 128: 323-327.
186. Yasui K, Kanda H, Iwanami T, Komiyama A,. Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation. Eur Respir J 2003; 22: 739-742.
187. van der Sluijs KF, van de Pol MA, Kulik W, Dijkhuis A, Smids BS, van Eijk HW, et al., Systemic tryptophan and kynurenine catabolite levels relate to severity of rhinovirus-induced asthma exacerbation: a prospective study with a parallel-group design. Thorax 2013; 68: 1122-1130.
188. Sano K, Yamauchi K, Hoshi H, Honma M, Tamura G, Shirato K,. CD44 expression on blood eosinophils is a novel marker of bronchial asthma. Int Arch Allergy Immunol 1997; 114 (Suppl 1): 67-71.
189. Gonzalez-Hernandez Y, Pedraza-Sanchez S, Blandon-Vijil V, del Rio-Navarro BE, Vaughan G, Moreno-Lafont M, et al., Peripheral blood CD161+ T cells from asthmatic patients are activated during asthma attack and predominantly produce IFN-gamma. Scand J Immunol 2007; 65: 368-375.
190. Julich H, Willms A, Lukacs-Kornek V, Kornek M,. Extracellular vesicle profiling and their use as potential disease specific biomarker. Front Immunol 2014; 5: 413.
191. Esser J, Gehrmann U, D'Alexandri FL, Hidalgo-Estevez AM, Wheelock CE, Scheynius A, et al., Exosomes from human macrophages and dendritic cells contain enzymes for leukotriene biosynthesis and promote granulocyte migration. J Allergy Clin Immunol 2010; 126: 1032-1040.
192. Torregrosa Paredes P, Esser J, Admyre C, Nord M, Rahman QK, Lukic A, et al., Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma. Allergy 2012; 67: 911-919.
193. Mazzeo C, Canas JA, Zafra MP, Rojas Marco A, Fernandez-Nieto M, Sanz V, et al., Exosome secretion by eosinophils: a possible role in asthma pathogenesis. J Allergy Clin Immunol 2015; 135: 1603-1613.
194. Wood LG, Garg ML, Simpson JL, Mori TA, Croft KD, Wark PA, et al., Induced sputum 8-isoprostane concentrations in inflammatory airway diseases. Am J Respir Crit Care Med 2005; 171: 426-430.
195. Kang YP, Lee WJ, Hong JY, Lee SB, Park JH, Kim D, et al., Novel approach for analysis of bronchoalveolar lavage fluid (BALF) using HPLC-QTOF-MS-based lipidomics: lipid levels in asthmatics and corticosteroid-treated asthmatic patients. J Proteome Res 2014; 13: 3919-3929.
196. Lundstrom SL, Yang J, Kallberg HJ, Thunberg S, Gafvelin G, Haeggstrom JZ, et al., Allergic asthmatics show divergent lipid mediator profiles from healthy controls both at baseline and following birch pollen provocation. PLoS One 2012; 7: e33780.
197. Mastalerz L, Celejewska-Wojcik N, Wojcik K, Gielicz A, Januszek R, Cholewa A, et al., Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity. Allergy 2014; 69: 1550-1559.
198. Dennis EA, Norris PC,. Eicosanoid storm in infection and inflammation. Nat Rev Immunol 2015; 15: 511-523.
199. Desai D, Gupta S, Siddiqui S, Singapuri A, Monteiro W, Entwisle J, et al., Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma. Respir Res 2013; 14: 17.
200. Noma T, Ichikawa K, Yoshizawa I, Aoki K, Kawano Y, Baba M,. Reduced IL-1 production in adolescents with mite antigen asthma in remission. Clin Exp Immunol 1998; 113: 10-16.
201. Baines KJ, Simpson JL, Wood LG, Scott RJ, Fibbens NL, Powell H, et al., Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes. J Allergy Clin Immunol 2014; 133: 997-1007.
202. Sim TC, Reece LM, Hilsmeier KA, Grant JA, Alam R,. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med 1995; 152: 927-933.
203. Li CW, Lu HG, de Chen H, Lin ZB, de Wang Y, Li TY,. In vivo and in vitro studies of Th17 response to specific immunotherapy in house dust mite-induced allergic rhinitis patients. PLoS One 2014; 9: e91950.
204. Neveu WA, Allard JL, Raymond DM, Bourassa LM, Burns SM, Bunn JY, et al., Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function. Respir Res 2010; 11: 28.
205. Rojas-Dotor S, Segura-Mendez NH, Miyagui-Namikawa K, Mondragon-Gonzalez R,. Expression of resistin, CXCR3, IP-10, CCR5 and MIP-1alpha in obese patients with different severity of asthma. Biol Res 2013; 46: 13-20.
206. Scaife A, Miller D, Spiteri-Cornish D, Turner SW, Devereux GS, Walsh GM,. Inhibitory effects of Montelukast on mediator release by nasal epithelial cells from asthmatic subjects with or without allergic rhinitis. Respir Med 2013; 107: 1859-1865.
207. Hamilton LM, Torres-Lozano C, Puddicombe SM, Richter A, Kimber I, Dearman RJ, et al., The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin Exp Allergy 2003; 33: 233-240.
208. Bonnans C, Chanez P, Chavis C,. Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation? Allergy 2004; 59: 1027-1041.
209. Yalcin AD, Bisgin A, Gorczynski RM,. IL-8, IL-10, TGF-beta, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment. Mediators Inflamm 2012; 2012: 720976.
210. van Benten IJ, van Drunen CM, Koevoet JL, Koopman LP, Hop WC, Osterhaus AD, et al., Reduced nasal IL-10 and enhanced TNFalpha responses during rhinovirus and RSV-induced upper respiratory tract infection in atopic and non-atopic infants. J Med Virol 2005; 75: 348-357.
211. Komai-Koma M, McKay A, Thomson L, McSharry C, Chalmers GW, Liew FY, et al., Immuno-regulatory cytokines in asthma: IL-15 and IL-13 in induced sputum. Clin Exp Allergy 2001; 31: 1441-1448.
212. Laza-Stanca V, Message SD, Edwards MR, Parker HL, Zdrenghea MT, Kebadze T, et al., The role of IL-15 deficiency in the pathogenesis of virus-induced asthma exacerbations. PLoS Pathog 2011; 7: e1002114.
213. Baumann R, Rabaszowski M, Stenin I, Tilgner L, Gaertner-Akerboom M, Scheckenbach K, et al., Nasal levels of soluble IL-33R ST2 and IL-16 in allergic rhinitis: inverse correlation trends with disease severity. Clin Exp Allergy 2013; 43: 1134-1143.
214. Kramer MF, Ostertag P, Pfrogner E, Rasp G,. Nasal IL-16 and MIP-1 alpha in late-phase allergic response. Allergy Asthma Proc 2001; 22: 127-132.
215. Nadi E, Arjipour M, Sharifi S, Zamani A,. Assay of IL-22 and IL-25 in serum, whole blood, and peripheral blood mononuclear cell cultures of patients with severe asthma. Allergol Immunopathol (Madr) 2014; 42: 402-406.
216. Stephenson ST, Brown LA, Helms MN, Qu H, Brown SD, Brown MR, et al., Cysteine oxidation impairs systemic glucocorticoid responsiveness in children with difficult-to-treat asthma. J Allergy Clin Immunol 2015; 136: 454-461.
217. Akelma AZ, Cizmeci MN, Kanburoglu MK, Bozkaya D, Catal F, Mete E, et al., Elevated level of serum osteopontin in school-age children with asthma. Allergol Immunopathol (Madr) 2014; 42: 275-281.
218. Mo JH, Kim JH, Lim DJ, Kim EH,. The role of hypoxia-inducible factor 1alpha in allergic rhinitis. Am J Rhinol Allergy 2014; 28: e100-e106.
219. Seys SF, Daenen M, Dilissen E, Van Thienen R, Bullens DM, Hespel P, et al., Effects of high altitude and cold air exposure on airway inflammation in patients with asthma. Thorax 2013; 68: 906-913.
220. Majak P, Juralowicz D, Jerzynska J, Smejda K, Stelmach W, Stelmach I,. Transforming growth factor-beta1 and IL-13 response to allergen predict steroid needs in asthmatic children. Pulm Pharmacol Ther 2013; 26: 290-295.
221. Folsgaard NV, Chawes BL, Bonnelykke K, Jenmalm MC, Bisgaard H,. Cord blood Th2-related chemokine CCL22 levels associate with elevated total-IgE during preschool age. Clin Exp Allergy 2012; 42: 1596-1603.
222. Hartl D, Latzin P, Zissel G, Krane M, Krauss-Etschmann S, Griese M,. Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Am J Respir Crit Care Med 2006; 173: 1370-1376.
223. Chien JW, Lin CY, Yang KD, Lin CH, Kao JK, Tsai YG,. Increased IL-17A secreting CD4+ T cells, serum IL-17 levels and exhaled nitric oxide are correlated with childhood asthma severity. Clin Exp Allergy 2013; 43: 1018-1026.
224. Yuksel H, Kirmaz C, Yilmaz O, Pinar E, Vatansever S, Degirmenci PB, et al., Nasal mucosal expression of nitric oxide synthases in patients with allergic rhinitis and its relation to asthma. Ann Allergy Asthma Immunol 2008; 100: 12-16.
225. Roos AB, Mori M, Gronneberg R, Osterlund C, Claesson HE, Wahlstrom J, et al., Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS. PLoS One 2014; 9: e90018.
226. Savenije OE, Mahachie John JM, Granell R, Kerkhof M, Dijk FN, de Jongste JC, et al., Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol 2014; 134: 170-177.
227. Rojas-Ramos E, Avalos AF, Perez-Fernandez L, Cuevas-Schacht F, Valencia-Maqueda E, Teran LM,. Role of the chemokines RANTES, monocyte chemotactic proteins-3 and -4, and eotaxins-1 and -2 in childhood asthma. Eur Respir J 2003; 22: 310-316.
228. Isgro M, Bianchetti L, Marini MA, Bellini A, Schmidt M, Mattoli S,. The C-C motif chemokine ligands CCL5, CCL11, and CCL24 induce the migration of circulating fibrocytes from patients with severe asthma. Mucosal Immunol 2013; 6: 718-727.
229. Tworek D, Kuna P, Mlynarski W, Gorski P, Pietras T, Antczak A,. MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis. Arch Med Sci 2013; 9: 849-853.
230. Pilette C, Francis JN, Till SJ, Durham SR,. CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge. Eur Respir J 2004; 23: 876-884.
231. Bobolea I, Barranco P, Del Pozo V, Romero D, Sanz V, Lopez-Carrasco V, et al., Sputum periostin in patients with different severe asthma phenotypes. Allergy 2015; 70: 540-546.
232. Kanemitsu Y, Ito I, Niimi A, Izuhara K, Ohta S, Ono J, et al., Osteopontin and periostin are associated with a 20-year decline of pulmonary function in patients with asthma. Am J Respir Crit Care Med 2014; 190: 472-474.
233. Hoshino M, Ohtawa J, Akitsu K,. Effect of treatment with inhaled corticosteroid on serum periostin levels in asthma. Respirology 2016; 21: 297-303.
234. Nagasaki T, Matsumoto H, Kanemitsu Y, Izuhara K, Tohda Y, Horiguchi T, et al., Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive asthma. Am J Respir Crit Care Med 2014; 190: 1449-1452.
235. Erlewyn-Lajeunesse MD, Hunt LP, Pohunek P, Dobson SJ, Kochhar P, Warner JA, et al., Bronchoalveolar lavage MMP-9 and TIMP-1 in preschool wheezers and their relationship to persistent wheeze. Pediatr Res 2008; 64: 194-199.
236. Mori S, Pawankar R, Ozu C, Nonaka M, Yagi T, Okubo K,. Expression and Roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in Allergic Nasal Mucosa. Allergy Asthma Immunol Res 2012; 4: 231-239.
237. Piirila P, Lauhio A, Majuri ML, Meuronen A, Myllarniemi M, Tervahartiala T, et al., Matrix metalloproteinases-7, -8, -9 and TIMP-1 in the follow-up of diisocyanate-induced asthma. Allergy 2010; 65: 61-68.
238. Falcai A, Soeiro-Pereira PV, Kubo CA, Aranda CS, Sole D, Condino-Neto A,. Peripheral blood mononuclear cells from severe asthmatic children release lower amounts of IL-12 and IL-4 after LPS stimulation. Allergol Immunopathol (Madr) 2015; 43: 482-486.
239. Sordillo JE, Kelly R, Bunyavanich S, McGeachie M, Qiu W, Croteau-Chonka DC, et al., Genome-wide expression profiles identify potential targets for gene-environment interactions in asthma severity. J Allergy Clin Immunol 2015; 136: 885-892.
240. Baumann R, Rabaszowski M, Stenin I, Gaertner-Akerboom M, Scheckenbach K, Wiltfang J, et al., The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms. Clin Transl Allergy 2012; 2: 13.
241. Schieck M, Michel S, Suttner K, Illig T, Zeilinger S, Franke A, et al., Genetic variation in TH17 pathway genes, childhood asthma, and total serum IgE levels. J Allergy Clin Immunol 2014; 133: 888-891.
242. Hossny EM, El-Sayed SS, El-Hadidi ES, Moussa SR,. Serum interleukin-18 expression in children with bronchial asthma. World Allergy Organ J 2009; 2: 63-68.
243. El-Mezayen RE, Matsumoto T,. In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis. Clin Immunol 2004; 111: 61-68.
244. Rovina N, Dima E, Bakakos P, Tseliou E, Kontogianni K, Papiris S, et al., Low interleukin (IL)-18 levels in sputum supernatants of patients with severe refractory asthma. Respir Med 2015; 109: 580-587.
245. Lluis A, Ballenberger N, Illi S, Schieck M, Kabesch M, Illig T, et al., Regulation of TH17 markers early in life through maternal farm exposure. J Allergy Clin Immunol 2014; 133: 864-871.
246. Lei Z, Liu G, Huang Q, Lv M, Zu R, Zhang GM, et al., SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma. Allergy 2008; 63: 327-332.
247. Stott B, Lavender P, Lehmann S, Pennino D, Durham S, Schmidt-Weber CB,. Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J Allergy Clin Immunol 2013; 132: 446-454.
248. Wright AK, Mistry V, Richardson M, Shelley M, Thornton T, Terry S, et al., Toll-like receptor 9 dependent interferon-alpha release is impaired in severe asthma but is not associated with exacerbation frequency. Immunobiology 2015; 220: 859-864.
249. Kato M, Yamada Y, Maruyama K, Hayashi Y,. Serum eosinophil cationic protein and 27 cytokines/chemokines in acute exacerbation of childhood asthma. Int Arch Allergy Immunol 2010; 152 (Suppl 1): 62-66.
250. Sousa AR, Lane SJ, Nakhosteen JA, Yoshimura T, Lee TH, Poston RN,. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol 1994; 10: 142-147.
251. Uller L, Emanuelsson CA, Andersson M, Erjefalt JS, Greiff L, Persson CG,. Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis. Respir Res 2010; 11: 54.
252. Thomas PS, Heywood G,. Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. Thorax 2002; 57: 774-778.
253. Vesaluoma M, Rosenberg ME, Teppo A, Gronhagen-Riska C, Haahtela T, Tervo T,. Tumour necrosis factor alpha (TNFalpha) in tears of atopic patients after conjunctival allergen challenge. Clin Exp Allergy 1999; 29: 537-542.
254. Yanai M, Sato K, Aoki N, Takiyama Y, Oikawa K, Kobayashi H, et al., The role of CCL22/macrophage-derived chemokine in allergic rhinitis. Clin Immunol 2007; 125: 291-298.
255. Ko FW, Lau CY, Leung TF, Wong GW, Lam CW, Lai CK, et al., Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients. Clin Exp Allergy 2006; 36: 44-51.
256. Navratil M, Plavec D, Dodig S, Jelcic Z, Nogalo B, Erceg D, et al., Markers of systemic and lung inflammation in childhood asthma. J Asthma 2009; 46: 822-828.
257. Shimoda T, Obase Y, Kishikawa R, Iwanaga T,. Serum high-sensitivity C-reactive protein can be an airway inflammation predictor in bronchial asthma. Allergy Asthma Proc 2015; 36: e23-e28.
258. Kasperska-Zajac A, Brzoza Z, Rogala B,. Seasonal changes in platelet activity in pollen-induced seasonal allergic rhinitis and asthma. J Asthma 2008; 45: 485-487.
259. Tutluoglu B, Gurel CB, Ozdas SB, Musellim B, Erturan S, Anakkaya AN, et al., Platelet function and fibrinolytic activity in patients with bronchial asthma. Clin Appl Thromb Hemost 2005; 11: 77-81.
260. Meng C, Sha J, Li L, An L, Zhu X, Meng X, et al., The expression and significance of immunoglobulin free light chain in the patients with allergic rhinitis and nonallergic rhinitis. Am J Rhinol Allergy 2014; 28: 302-307.
261. Krug N, Tschernig T, Erpenbeck VJ, Hohlfeld JM, Kohl J,. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Respir Crit Care Med 2001; 164: 1841-1843.
262. Johansson MW,. Activation states of blood eosinophils in asthma. Clin Exp Allergy 2014; 44: 482-498.
263. Braun RK, Foerster M, Workalemahu G, Haefner D, Kroegel C, Walker C,. Differential regulation of aminopeptidase N (CD13) by transendothelial migration and cytokines on human eosinophils. Exp Lung Res 2003; 29: 59-77.
264. Bates ME, Liu LY, Esnault S, Stout BA, Fonkem E, Kung V, et al., Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils. Am J Respir Cell Mol Biol 2004; 30: 736-743.
265. Kanters D, ten Hove W, Luijk B, van Aalst C, Schweizer RC, Lammers JW, et al., Expression of activated Fc gamma RII discriminates between multiple granulocyte-priming phenotypes in peripheral blood of allergic asthmatic subjects. J Allergy Clin Immunol 2007; 120: 1073-1081.
266. Zhang PL, Pennington JR, Prichard JW, Blasick TM, Brown AM, Potdar S,. CD52 antigen may be a therapeutic target for eosinophilic rhinosinusitis. Ann Clin Lab Sci 2007; 37: 148-151.
267. Mengelers HJ, Maikoe T, Brinkman L, Hooibrink B, Lammers JW, Koenderman L,. Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics. Am J Respir Crit Care Med 1994; 149: 345-351.
268. Gerard NP, Hodges MK, Drazen JM, Weller PF, Gerard C,. Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem 1989; 264: 1760-1766.
269. Esnault S, Kelly EA, Johansson MW, Liu LY, Han ST, Akhtar M, et al., Semaphorin 7A is expressed on airway eosinophils and upregulated by IL-5 family cytokines. Clin Immunol 2014; 150: 90-100.
270. Sabroe I, Hartnell A, Jopling LA, Bel S, Ponath PD, Pease JE, et al., Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol 1999; 162: 2946-2955.
271. Bohm E, Sturm GJ, Weiglhofer I, Sandig H, Shichijo M, McNamee A, et al., 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. J Biol Chem 2004; 279: 7663-7670.
272. Gervais FG, Cruz RP, Chateauneuf A, Gale S, Sawyer N, Nantel F, et al., Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol 2001; 108: 982-988.
273. Gao P, Gibson PG, Baines KJ, Yang IA, Upham JW, Reynolds PN, et al., Anti-inflammatory deficiencies in neutrophilic asthma: reduced galectin-3 and IL-1RA/IL-1beta. Respir Res 2015; 16: 5.
274. Kiwamoto T, Kawasaki N, Paulson JC, Bochner BS,. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. Pharmacol Ther 2012; 135: 327-336.
275. Kiwamoto T, Katoh T, Tiemeyer M, Bochner BS,. The role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation. Curr Opin Allergy Clin Immunol 2013; 13: 106-111.
276. Mann BS, Chung KF,. Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapy. Respir Res 2006; 7: 59.
277. Svendsen ER, Yeatts KB, Peden D, Orton S, Alexis NE, Creason J, et al., Circulating neutrophil CD14 expression and the inverse association of ambient particulate matter on lung function in asthmatic children. Ann Allergy Asthma Immunol 2007; 99: 244-253.
278. Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG,. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 2007; 62: 211-218.
279. Costantini C, Micheletti A, Calzetti F, Perbellini O, Pizzolo G, Cassatella MA,. Neutrophil activation and survival are modulated by interaction with NK cells. Int Immunol 2010; 22: 827-838.
280. Fortunati E, Kazemier KM, Grutters JC, Koenderman L, Van den Bosch VJ,. Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease. Clin Exp Immunol 2009; 155: 559-566.
281. Nair P, Gaga M, Zervas E, Alagha K, Hargreave FE, O'Byrne PM, et al., Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy 2012; 42: 1097-1103.
282. Yoshimura C, Yamaguchi M, Iikura M, Izumi S, Kudo K, Nagase H, et al., Activation markers of human basophils: CD69 expression is strongly and preferentially induced by IL-3. J Allergy Clin Immunol 2002; 109: 817-823.
283. Abuaf N, Rostane H, Rajoely B, Gaouar H, Autegarden JE, Leynadier F, et al., Comparison of two basophil activation markers CD63 and CD203c in the diagnosis of amoxicillin allergy. Clin Exp Allergy 2008; 38: 921-928.
284. Hausmann OV, Gentinetta T, Fux M, Ducrest S, Pichler WJ, Dahinden CA,. Robust expression of CCR3 as a single basophil selection marker in flow cytometry. Allergy 2011; 66: 85-91.
285. Boumiza R, Debard AL, Monneret G,. The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy 2005; 3: 9.
286. Holgate ST,. New strategies with anti-IgE in allergic diseases. World Allergy Organ J 2014; 7: 17.
287. Schafer T, Starkl P, Allard C, Wolf RM, Schweighoffer T,. A granular variant of CD63 is a regulator of repeated human mast cell degranulation. Allergy 2010; 65: 1242-1255.
288. Bonadonna P, Bonifacio M, Lombardo C, Zanotti R,. Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association. Curr Allergy Asthma Rep 2015; 15: 49.
289. Brightling CE, Kaur D, Berger P, Morgan AJ, Wardlaw AJ, Bradding P,. Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration. J Leukoc Biol 2005; 77: 759-766.
290. Andersson CK, Tufvesson E, Aronsson D, Bergqvist A, Mori M, Bjermer L, et al., Alveolar mast cells shift to an FcepsilonRI-expressing phenotype in mild atopic asthma: a novel feature in allergic asthma pathology. Allergy 2011; 66: 1590-1597.
291. Balhara J, Gounni AS,. The alveolar macrophages in asthma: a double-edged sword. Mucosal Immunol 2012; 5: 605-609.
292. Harmanci E, Gulbas Z, Ozdemir N, Elbek O, Isik R,. Lymphocyte subtypes in asthma: relationship with the clinical status and bronchial hyperreactivity. Allerg Immunol (Paris) 1998; 30: 245-248.
293. Garg S, Ramamurthy T, Mukhopadhyay AK, Deb BC, Nair GB, Shimada T, et al., Production and cross-reactivity patterns of a panel of high affinity monoclonal antibodies to Vibrio cholerae O139 Bengal. FEMS Immunol Med Microbiol 1994; 8: 293-298.
294. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, et al., Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12: 1045-1054.
295. McKenzie AN,. Type-2 innate lymphoid cells in asthma and allergy. Ann Am Thorac Soc 2014; 11 (Suppl 5): S263-S270.
296. Hamzaoui A, Kahan A, Ayed K, Hamzaoui K,. T cells expressing the gammadelta receptor are essential for Th2-mediated inflammation in patients with acute exacerbation of asthma. Mediators Inflamm 2002; 11: 113-119.
297. Mohammadi Nejad M, Salehi E, Mesdaghi M, Atarod L, Movahedi M, Gheflati Z, et al., Increased expression of CD69 antigen on human peripheral blood natural killer cells in patients with allergic rhinitis. Iran J Allergy Asthma Immunol 2013; 12: 68-74.
298. Awad A, Yassine H, Barrier M, Vorng H, Marquillies P, Tsicopoulos A, et al., Natural killer cells induce eosinophil activation and apoptosis. PLoS One 2014; 9: e94492.
299. Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Kazani S, et al., Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med 2013; 5: 174ra126.
300. Lee HH, Meyer EH, Goya S, Pichavant M, Kim HY, Bu X, et al., Apoptotic cells activate NKT cells through T cell Ig-like mucin-like-1 resulting in airway hyperreactivity. J Immunol 2010; 185: 5225-5235.
301. Gagro A, Rabatic S, Lokar-Kolbas R, Medar-Lasic M, Zimic L,. Effect of an asthmatic attack on CD23 and CD21 expression on lymphocytes from allergic children during the allergen season. Clin Exp Allergy 1995; 25: 690-697.
302. Chan MA, Gigliotti NM, Aubin BG, Rosenwasser LJ,. FCER2 (CD23) asthma-related single nucleotide polymorphisms yields increased IgE binding and Egr-1 expression in human B cells. Am J Respir Cell Mol Biol 2014; 50: 263-269.
303. van der Vlugt LE, Mlejnek E, Ozir-Fazalalikhan A, Janssen Bonas M, Dijksman TR, Labuda LA, et al., CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide. Clin Exp Allergy 2014; 44: 517-528.
304. Farres MN, Sabry MK, Ahmed EE, Elkady HM, Mohamed NA,. OX40 ligand: a potential costimulatory molecule in atopic asthma. J Asthma 2014; 51: 573-577.
305. Chen Y, Lind Enoksson S, Johansson C, Karlsson MA, Lundeberg L, Nilsson G, et al., The expression of BAFF, APRIL and TWEAK is altered in eczema skin but not in the circulation of atopic and seborrheic eczema patients. PLoS One 2011; 6: e22202.
306. James ES, Harney S, Wordsworth BP, Cookson WO, Davis SJ, Moffatt MF,. PDCD1: a tissue-specific susceptibility locus for inherited inflammatory disorders. Genes Immun 2005; 6: 430-437.
307. Takhar P, Corrigan CJ, Smurthwaite L, O'Connor BJ, Durham SR, Lee TH, et al., Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J Allergy Clin Immunol 2007; 119: 213-218.
308. Stelmaszczyk-Emmel A, Zawadzka-Krajewska A, Szypowska A, Kulus M, Demkow U,. Frequency and activation of CD4+CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy. Int Arch Allergy Immunol 2013; 162: 16-24.
309. Urra JM, Carrasco P, Feo-Brito F, De La Roca F, Guerra F, Cabrera CM,. Immunotherapy reduces CD40L expression and modifies cytokine production in the CD4 cells of pollen allergy patients. J Investig Allergol Clin Immunol 2014; 24: 98-105.
310. Archila LD, Jeong D, Pascal M, Bartra J, Juan M, Robinson D, et al., Jug r 2-reactive CD4(+) T cells have a dominant immune role in walnut allergy. J Allergy Clin Immunol 2015; 136: 983-992.
311. Lee JH, Yu HH, Wang LC, Yang YH, Lin YT, Chiang BL,. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 2007; 148: 53-63.
312. Corrigan CJ, Haczku A, Gemou-Engesaeth V, Doi S, Kikuchi Y, Takatsu K, et al., CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis 1993; 147: 540-547.
313. Schade RP, Van Ieperen-Van Dijk AG, Versluis C, Van Reijsen FC, Kimpen JL, Bruijnzeel-Koomen CA, et al., Cell-surface expression of CD25, CD26, and CD30 by allergen-specific T cells is intrinsically different in cow's milk allergy. J Allergy Clin Immunol 2002; 109: 357-362.
314. Lun SW, Wong CK, Ko FW, Hui DS, Lam CW,. Increased expression of plasma and CD4+ T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthma. J Clin Immunol 2007; 27: 430-437.
315. Gluck J, Rymarczyk B, Rogala B,. Chemokine receptors expression on CD3+ blood cells in bronchial asthma. Adv Med Sci 2015; 61: 11-17.
316. Wang J, Xu Y, Zhao H, Sui H, Liang H, Jiang X,. Genetic variations in chemoattractant receptor expressed on Th2 cells (CRTH2) is associated with asthma susceptibility in Chinese children. Mol Biol Rep 2009; 36: 1549-1553.
317. Hall IP, Fowler AV, Gupta A, Tetzlaff K, Nivens MC, Sarno M, et al., Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment. Pulm Pharmacol Ther 2015; 32: 37-44.
318. Wang LL, Tang PH, Shi CG, Wan YH, Tang W, Hou XX, et al., Expression of CD39 mRNA is altered in the peripheral blood of patients with allergic asthma. Biomed Rep 2014; 2: 75-78.
319. Nanzer AM, Chambers ES, Ryanna K, Richards DF, Black C, Timms PM, et al., Enhanced production of IL-17A in patients with severe asthma is inhibited by 1alpha,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion. J Allergy Clin Immunol 2013; 132: 297-304.
320. Lee N, You S, Shin MS, Lee WW, Kang KS, Kim SH, et al., IL-6 receptor alpha defines effector memory CD8+ T cells producing Th2 cytokines and expanding in asthma. Am J Respir Crit Care Med 2014; 190: 1383-1394.